The global nucleic acid isolation and purification market is expected to reach USD 3,837.42 million by 2020 from USD 2,560.31 million in 2015, growing at a CAGR of 8.43% between 2015 and 2020. The product segments included in this report are instruments, kits, and reagents. On the basis of technology, the nucleic acid isolation and purification market is segmented into column-based isolation and purification, reagent-based isolation and purification, magnetic bead-based isolation and purification, and other technologies. On the basis of application, the nucleic acid isolation and purification market is segmented into plasmid DNA isolation and purification, total RNA isolation and purification, blood DNA isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR clean-up and other applications. On the basis of end user, the nucleic acid isolation and purification market is segmented into academic and government research institutes, pharmaceutical and biotechnology companies, contract research organizations, hospitals and diagnostic centers, and other end users.

The geographic segments included in this report are North America, Europe, Asia and Rest of the World (RoW). The geographic analysis reveals that North America accounted for the largest share in the global nucleic acid isolation and purification market in 2015. Asia regional segment, on the other hand, is expected to register a faster growth from 2015 to 2020.

The key driver for this market are increasing R&D expenditures, technological advancements and increasing automation, availability of benchtop instruments, and increasing investments from pharma companies.

A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global nucleic acid isolation and purification market and its sub-segments. Secondary information was used to identify the overall revenues, geographic reach, and product portfolios of the market players. Estimates of their nucleic acid isolation and purification product segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine percentage shares of each sub segment and the relative differences in the growth rates. The report provides qualitative insights about key market shares, growth rates, and market drivers for all important sub segments. It maps the market sizes and growth rates of each sub segment and identifies the segments poised for rapid growth in each of the geographic segments. The report also includes company profiles of the market leaders. These company profiles include financial performances, product portfolios, and market developments for each company. The report also provides a competitive landscape of the cell-based assays market. The competitive landscape covers the growth strategies adopted by the industry players over the last four years. It also includes analysis of industry developments like expansions, agreements and partnerships, mergers and acquisitions and new product launches.

Reasons to Buy the Report: The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions. The report provides insights on the following: • Product Development: Product portfolios of the top players in the cell-based assays market. • Competitive Assessment: In-depth assessment of the market shares, strategies, geographic and business segments, and product portfolios of the leading players in the cell-based assays market. • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the market for various cell-based assays products across geographies.